These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2827831)

  • 21. In vitro differentiation of peripheral blood T cells towards a type 2 phenotype is impaired in rheumatoid arthritis (RA).
    Asselin S; Conjeaud H; Fradelizi D; Breban M
    Clin Exp Immunol; 1998 Nov; 114(2):284-92. PubMed ID: 9822289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human recombinant IL-2 augments immunoglobulin and induces rheumatoid factor production by rheumatoid arthritis lymphocytes engrafted into severe combined immunodeficient mice.
    Kaul R; Sharma A; Lisse JR; Christadoss P
    Clin Immunol Immunopathol; 1995 Mar; 74(3):271-82. PubMed ID: 7859417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of dexamethasone on lymphocyte proliferation and cytokine production in rheumatoid arthritis.
    De A; Blotta HM; Mamoni RL; Louzada P; Bertolo MB; Foss NT; Moreira AC; Castro M
    J Rheumatol; 2002 Jan; 29(1):46-51. PubMed ID: 11824970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IgE production by normal human B cells induced by alloreactive T cell clones is mediated by IL-4 and suppressed by IFN-gamma.
    Pène J; Rousset F; Brière F; Chrétien I; Paliard X; Banchereau J; Spits H; De Vries JE
    J Immunol; 1988 Aug; 141(4):1218-24. PubMed ID: 3135324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of activated killer (AK) cells by recombinant interleukin 2 (rIL 2) in collaboration with interferon-gamma (IFN-gamma).
    Itoh K; Shiiba K; Shimizu Y; Suzuki R; Kumagai K
    J Immunol; 1985 May; 134(5):3124-9. PubMed ID: 2984283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitogen-induced interleukin 2 and gamma interferon production by CD4+ and CD8+ cells of patients with inflammatory arthritides. A comparison between cells from synovial fluid and peripheral blood.
    Hovdenes J; Gaudernack G; Kvien TK; Hovdenes AB; Egeland T
    Scand J Immunol; 1989 Nov; 30(5):597-603. PubMed ID: 2511620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production and regulation of interleukin 6 in human B lymphoid cells.
    Hutchins D; Cohen BB; Steel CM
    Eur J Immunol; 1990 May; 20(5):961-8. PubMed ID: 2113479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High level of interleukin-10 production by the activated T cell population within the rheumatoid synovial membrane.
    Cohen SB; Katsikis PD; Chu CQ; Thomssen H; Webb LM; Maini RN; Londei M; Feldmann M
    Arthritis Rheum; 1995 Jul; 38(7):946-52. PubMed ID: 7612044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin 4 inhibits the interleukin 2-induced production of its functional antagonist, interferon gamma.
    Wagner F; Fischer N; Lersch C; Hart R; Dancygier H
    Immunol Lett; 1989 Jun; 21(3):237-41. PubMed ID: 2504666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Demonstration of impaired T cell regulation of Epstein-Barr virus stimulated B lymphocytes in rheumatoid arthritis with HLA identical, disease discordant sibling pairs.
    Fawcett MC; Walker DJ; Griffiths ID
    Ann Rheum Dis; 1988 May; 47(5):372-6. PubMed ID: 2839121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human alpha-interferon enhances in vitro IgM rheumatoid factor synthesis by lymphocytes from normal subjects and rheumatoid arthritis patients.
    Rodriguez MA; Prinz WA; Sibbitt WL; Bankhurst AD; Williams RC
    Arthritis Rheum; 1983 Sep; 26(9):1091-7. PubMed ID: 6311224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [In vivo and vitro effects of interferon-alpha 2b on functional activity of T-lymphocytes from patients with rheumatoid arthritis].
    Iarilina AA; Nikonova MF; Litvina MM; Balabanova RM; Iarilin AA
    Ter Arkh; 2000; 72(5):9-17. PubMed ID: 11109610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon-gamma-inducing activity of interleukin-18 in the joint with rheumatoid arthritis.
    Yamamura M; Kawashima M; Taniai M; Yamauchi H; Tanimoto T; Kurimoto M; Morita Y; Ohmoto Y; Makino H
    Arthritis Rheum; 2001 Feb; 44(2):275-85. PubMed ID: 11229457
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterogeneity of helper/inducer T lymphocytes. II. Effects of interleukin 4- and interleukin 2-producing T cell clones on resting B lymphocytes.
    Boom WH; Liano D; Abbas AK
    J Exp Med; 1988 Apr; 167(4):1350-63. PubMed ID: 2965736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro production of interferon-gamma by peripheral blood from patients with Graves' disease, Hashimoto's thyroiditis and rheumatoid arthritis.
    Matsubayashi S; Akasu F; Kasuga Y; Snow K; Keystone E; Volpé R
    Clin Exp Immunol; 1990 Oct; 82(1):63-8. PubMed ID: 1976464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-12 stimulates B cell growth by inducing IFN-gamma.
    Li L; Young D; Wolf SF; Choi YS
    Cell Immunol; 1996 Mar; 168(2):133-40. PubMed ID: 8640858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accessory function of human fibroblasts in mitogen-stimulated interferon-gamma production by T lymphocytes. Inhibition by interleukin 1 and tumor necrosis factor.
    Le JM; Vilcek J
    J Immunol; 1987 Nov; 139(10):3330-7. PubMed ID: 3119705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1,25-Dihydroxyvitamin D3 modulates the effects of interleukin 2 independent of IL-2 receptor binding.
    Rigby WF; Hamilton BJ; Waugh MG
    Cell Immunol; 1990 Feb; 125(2):396-414. PubMed ID: 2105168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripheral blood lymphocytes resistant to Epstein-Barr virus immortalization manifest high natural killer (NK) type activity against NK-resistant target cells.
    Gosselin J; Menezes J; Mercier G; Lamoureux G; Oth D
    Viral Immunol; 1990; 3(1):55-65. PubMed ID: 2153385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the role of interferon-gamma, interleukin 2 and a third factor distinct from interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation.
    Romagnani S; Giudizi GM; Almerigogna F; Biagiotti R; Alessi A; Mingari C; Liang CM; Moretta L; Ricci M
    Eur J Immunol; 1986 Jun; 16(6):623-9. PubMed ID: 3087756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.